Targeting PI3K/Akt/mTOR in AML: rationale and clinical evidence

S Darici, H Alkhaldi, G Horne, HG Jørgensen… - Journal of Clinical …, 2020 - mdpi.com
Acute myeloid leukemia (AML) is a highly heterogeneous hematopoietic malignancy
characterized by excessive proliferation and accumulation of immature myeloid blasts in the …

[HTML][HTML] The role of autophagy in resistance to targeted therapies

L Mele, V Del Vecchio, D Liccardo, C Prisco… - Cancer Treatment …, 2020 - Elsevier
Autophagy is a self-degradative cellular process, involved in stress response such as
starvation, hypoxia, and oxidative stress. This mechanism balances macro-molecule …

A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch

Y Sun, Q He, J Li, Z Yang, M Ahmad, Y Lin, D Wu… - Cell Death & …, 2023 - nature.com
Lactic acidosis is a feature of solid tumors and plays fundamental role (s) rendering cancer
cells to adapt to diverse metabolic stresses, but the mechanism underlying its roles in redox …

Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: A review

P Singh, V Kumar, SK Gupta, G Kumari, M Verma - Medical Oncology, 2021 - Springer
Chronic myeloid leukemia (CML), a myeloproliferative hematopoietic cancer, is caused by a
genetic translocation between chromosomes 9 and 22. This translocation produces a small …

Mechanisms of resistance and implications for treatment strategies in chronic myeloid leukaemia

G Poudel, MG Tolland, TP Hughes, IS Pagani - Cancers, 2022 - mdpi.com
Simple Summary Chronic myeloid leukaemia (CML) is a type of blood cancer that is
currently well-managed with drugs that target cancer-causing proteins. However, a …

Utilizing stimulated Raman scattering microscopy to study intracellular distribution of label-free ponatinib in live cells

K Sepp, M Lee, MTJ Bluntzer… - Journal of medicinal …, 2019 - ACS Publications
Stimulated Raman scattering (SRS) microscopy represents a powerful method for imaging
label-free drug distribution with high resolution. SRS was applied to image label-free …

Understanding the role of autophagy in cancer formation and progression is a real opportunity to treat and cure human cancers

S Patergnani, S Missiroli, G Morciano, M Perrone… - Cancers, 2021 - mdpi.com
Simple Summary The modulation of autophagy represents a potential therapeutic strategy
for cancer. More than one hundred clinical trials have been conducted or are ongoing to …

Regulation of beclin 1-mediated autophagy by oncogenic tyrosine kinases

S Vega-Rubín-de-Celis, L Kinch… - International journal of …, 2020 - mdpi.com
Beclin 1 is a major regulator of autophagy, and it is a core component of the class III PI3K
complexes. Beclin 1 is a highly conserved protein and its function is regulated in a number …

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with …

GA Horne, J Stobo, C Kelly, A Mukhopadhyay, AL Latif… - Leukemia, 2020 - nature.com
In chronic-phase chronic myeloid leukaemia (CP-CML), residual BCR-ABL1+ leukaemia
stem cells are responsible for disease persistence despite TKI. Based on in vitro data …

The role of exosomal microRNA in cancer drug resistance

Q Guo, H Wang, Y Yan, Y Liu, C Su, H Chen… - Frontiers in …, 2020 - frontiersin.org
Exosomes affect the initiation and progression of cancers. In the tumor microenvironment,
not only cancer cells, but also fibroblasts and immunocytes secrete exosomes. Exosomes …